Search

Your search keyword '"Marco Moia"' showing total 114 results

Search Constraints

Start Over You searched for: Author "Marco Moia" Remove constraint Author: "Marco Moia"
114 results on '"Marco Moia"'

Search Results

1. The effect of health literacy on vaccine hesitancy among Italian anticoagulated population during COVID-19 pandemic: the moderating role of health engagement

2. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

3. Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonists

4. Different Lung Parenchyma Quantification Using Dissimilar Segmentation Software: A Multi-Center Study for COVID-19 Patients

6. Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population.

7. Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry

8. 36-month clinical outcomes of patients with venous thromboembolism

9. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

10. Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

11. Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper

12. The effect of health literacy on vaccine hesitancy among Italian anticoagulated population during COVID-19 pandemic: the moderating role of health engagement

13. Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonists

14. The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures

15. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients

16. Reversal agents for oral anticoagulant-associated major or life-threatening bleeding

17. Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists

18. Evaluation of a new PT-INR monitoring system in patients with the antiphospholipid syndrome

19. Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals

20. How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues

21. 4110Thromboembolic and bleeding risk of patients with left-sided mechanical heart prostheses: the FCSA-START-Valvole Study

22. Correction to: Reversal agents for oral anticoagulant-associated major or life-threatening bleeding

23. Laboratory tests during direct oral anticoagulant treatment

24. Correction: Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population

25. Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population

26. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis

27. The cost‐effectiveness of computer‐assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study

28. Renal allograft thrombosis

29. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

30. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis

31. The LONFLIT4-Concorde Deep Venous Thrombosis and Edema Study: Prevention with Travel Stockings

32. The LONFLIT4-Concorde - Sigvaris Traveno Stockings in Long Flights (EcoTraS) Study

33. Treatment of Thrombosis in Antiphospholipid Syndrome

34. New oral anticoagulants in thrombotic antiphospholipid syndrome

35. Comments on: Laboratory tests for the management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants: Proposals of the Working Group on Perioperative Haemostasis (GIHP)

36. Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

37. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis

38. Accuracy of a Portable Prothrombin Time Monitor (Coagucheck) in Patients on Chronic Oral Anticoagulant Therapy

39. Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities

40. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

41. Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial

42. Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms

43. Patient Preferences and Willingness to Pay for different Options of Anticoagulant Therapy

44. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

45. Biological variation of INR in stable patients on long-term anticoagulation with warfarin

46. The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation

47. Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

48. A Pilot Study of Pro-Urokinase in the Treatment of Deep Vein Thrombosis

49. Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry

50. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies

Catalog

Books, media, physical & digital resources